메뉴바로가기 본문바로가기

vision

인류의 안전과 건강 증진에 기여하는 기업, (주)인테라입니다.

InThera is exploring the innovative technology and novel products in rapidly advancing infectious disease market

Through the development of innovative prophylactic & therapeutic biopharmaceutical products, InThera aims to lead the technology and products in the field of infectious disease market

2016 ~ 2019

·Platform Technology & R&D Infra Establishment

·Product Development

·R&D Pipeline

Turning Point 2020

·Regulatory Approval and Launch of FMDV Vaccine

·Entry into Domestic and Overseas Market & Expansion of M/S

·Clinical Development of Novel Vaccine

·IPO

2024

·NDA of Novel Vaccine

·Regulatory Approval and Launch of Novel Vaccine

·Clinical Development of Therapeutic Vaccine